VLDB 2026 Research / reviewers in the wild / expert
Lingzhi Qu
dblp:255/2285
· DBLP profile ↗
2ranked-venue papers
0as first author
2since 2021 · last 2023
0000-0002-8212-6605ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 2 · 2 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 1 heaviest of 1, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › drug discovery
drug side effect prediction |
0.7 | 1 | 2023 | Prediction of drug side effects with transductive matrix co-completion · Bioinform. 2023 |
Methods — techniques the papers use, named apart from their topics
transductive matrix co-completion · 0.7positive-unlabelled learning · 0.7graph regularization · 0.7
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2023 | Prediction of drug side effects with transductive matrix co-completionabstractMOTIVATION: Side effects of drugs could cause severe health problems and the failure of drug development. Drug-target interactions are the basis for side effect production and are important for side effect prediction. However, the information on the known targets of drugs is incomplete. Furthermore, there could be also some missing data in the existing side effect profile of drugs. As a result, new methods are needed to deal with the missing features and missing labels in the problem of side effect prediction. RESULTS: We propose a novel computational method based on transductive matrix co-completion and leverage the low-rank structure in the side effects and drug-target data. Positive-unlabelled learning is incorporated into the model to handle the impact of unobserved data. We also introduce graph regularization to integrate the drug chemical information for side effect prediction. We collect the data on side effects, drug targets, drug-associated proteins and drug chemical structures to train our model and test its performance for side effect prediction. The experiment results show that our method outperforms several other state-of-the-art methods under different scenarios. The case study and additional analysis illustrate that the proposed method could not only predict the side effects of drugs but also could infer the missing targets of drugs. AVAILABILITY AND IMPLEMENTATION: The data and the code for the proposed method are available at https://github.com/LiangXujun/GTMCC. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Xujun Liang, Lingzhi Qu, Yongheng Chen |
Bioinform. | 3 |
| 2022 | A novel machine learning model based on sparse structure learning with adaptive graph regularization for predicting drug side effects
Xujun Liang, Lingzhi Qu, Yuying Tan, Pengfei Zhang 0009 |
J. Biomed. Informatics | 4 |